Novartis opened its Argentine subsidiary in 1931 and, to this day, more than 350 multidisciplinary professionals work collaboratively on a daily basis seeking disruptive solutions to transform health standards in the areas of: oncology, gene therapy, neurosciences, immunology and cardiovascular.